Activation of G-Proteins by Morphine and Codeine Congeners: Insights to the Relevance of O- and N-Demethylated Metabolites at μ- and δ-Opioid Receptors

2004/01/27 by Chad M. Thompson, Heidi Wojno, Elisabeth Greiner +3 · 5 citations
Biochemistry, Genetics and Molecular Biology · Neuroscience · #Neuropeptides and Animal Physiology #Pharmacological Receptor Mechanisms and Effects #Receptor Mechanisms and Signaling

paper · doi:10.1124/jpet.103.058602

openalex publication_date 2004/01/27 · crossref created 2004/01/27 · crossref issued 2004/02/01 · crossref published 2004/02/01 · crossref published-print 2004/02/01 · openalex created_date 2016/06/24 · crossref deposited 2025/02/19 · crossref indexed 2026/04/03 · openalex updated_date 2026/08/01

Cited by

• How different is oxycodone from morphine?
• Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites
• Pharmacological Characterization of Noroxymorphone as a New Opioid for Spinal Analgesia
• Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety
• Hydrocodone [wikipedia]